MEDICINES CO /DE company info

CIK 1113481
IRS Number 043324394
State of incorporation DE
Business address 8 SYLVAN WAY
None
PARSIPPANY
NJ
07054
Mail address 8 SYLVAN WAY
None
PARSIPPANY
NJ
07054

Short summary

MEDICINES CO /DE is a New Jersey company, with head office located at 8 Sylvan Way Parsippany, New Jersey 07054. In 2017 the company owned a total of 1.01 billion USD worth of assets, including 297.84 million USD worth of current assets. 2014 was the year when the company amassed the most assets.

MEDICINES CO /DE Income Statement

Name [in Millions USD]20072008200920102011201220132014201520162017Trends
Revenue, Net 348.16404.24437.65484.73558.59687.86724.41309.01167.84
Cost of Goods and Services Sold 88.36118.15129.30156.87177.34262.79287.63119.9371.35
Selling, General and Administrative Expense 164.90193.83158.69159.62171.75264.96342.16337.94319.15
Research and development 105.72117.6185.24110.18126.42146.93159.18123.61139.26
Operating Income (Loss) -10.82-25.3564.4258.0783.0713.19-28.11-272.47-361.93
Interest expense 008.0115.5315.7037.0944.46
Other Nonoperating Income (Expense) -2.82-0.271.791.141.580.920.400.33
Income Tax Expense (Benefit) 2.9248.06-40.49-50.0335.041.36-6.84-29.740.07
Net income -8.50-76.23104.64127.8851.1715.26-32.21-352.76-119.12

MEDICINES CO /DE Balance Sheet

Name [in Millions USD]20072008200920102011201220132014201520162017Trends
Cash and cash equivalents 88.1371.15101.70195.61452.34292.89368.27462.74644.20202.42166.73
Available-for-sale Securities, Current 117.118856.9050.90
Accounts Receivable, Net, Current 20.7267.0165.6690.33120.1252.6248.4115.577.79
Inventories 28.4229.1647.2086.7586.31127.7874.1271.4267.17
Deferred income taxes 09.4013.8813.4300
Property, Plant and Equipment, Gross 35.6735.4234.4160.7166.9063.1363.35
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment -15.01-17.44-18.3121.4426.8428.3532.39
Goodwill 14.6714.6714.67135.63284.82313.51255.63255.63255.63
Available-for-sale Securities, Noncurrent 5.108.20
Intangible Assets, Net (Excluding Goodwill) 81.74121.84462.49900.731,039.16628.16289.07285.97
Other Assets, Noncurrent 0.260.3014.7517.5615.0213.500.740.750.78
Total assets 403.18538.68897.871,149.921,847.112,066.631,852.441,151.111,006.98
Current assets 275.23389.60652.45502.64603.09660.45789.33436.03297.84
Accounts payable 7.9517.277.115.078.2617.7026.7216.5311.70
Total current liabilities 80.13103.84116.37120.62179.09208.70220.11515.29128.91
Deferred income taxes 19.25034.50149.25163.9588.3967.000
Total liabilities 130.31137.11365.28492.49936.851,094.841,021.53946.10818.93
Common Stock, Value, Issued 0.050.050.060.060.070.070.070.080.08
Retained Earnings (Accumulated Deficit) -319.32-203.86-90.34-53.89-55.05-118.67-339.87-1,048.92-1,079.10
Accumulated Other Comprehensive Income (Loss), Net of Tax -0.140.31-1.21-1.68-3.874.48-5.41-5.45-4.95

MEDICINES CO /DE Cash Flow

Name [in Millions USD]20072008200920102011201220132014201520162017Trends
Net income -8.50-76.23104.64127.8851.1715.26-32.21-352.76-119.12
Depreciation and amortization 2.935.776.12
Depreciation 4.604.403.602.903.905.604.703.70
Amortization of Intangible Assets 1.802.604.4028.5032.201725.80
Depreciation and amortization 5.776.126.237.2732.2434.4034.8431.04
Deferred Income Tax Expense (Benefit) 1.5247.74-43.59-53.2530.38-10.27-5.57-53.29-0.02
Accounts receivable 7.61-3.1816.6328.0911.1215.0254.74-103.10-30.14
Inventories -6.89-2.77-0.7019.7931.1510.13-5.6369.3215.65
Accounts payable 3.32-7.850.17-2.2018.90-1.32-6.8716.36-7.40
Deferred revenue 9.59-8.52-0.620.131.693.855.268.391.57
Net Cash Provided by (Used in) Operating Activities 38.080.9567.4796.3846.3591.4267.31-197.97-323.31
Payments to Acquire Property, Plant, and Equipment 19.400.340.341.271.0113.577.292.562.18
Payments to Acquire Businesses, Net of Cash Acquired 23.5337.17-0.2600542.5858.9328.400
Payments to Acquire Intangible Assets 200736.68015112.6210
Net Cash Provided by (Used in) Investing Activities -50.25-11.22-18.4078.41-63.51-504.36-84.76-123.51422.04
Proceeds from Issuance of Common Stock 5.541.803.366.7322.9474.2117.3495.2033.78
Payments for Repurchase of Common Stock 005000
Net Cash Provided by (Used in) Financing Activities 5.541.803.3616.12220.92271.498.83324.8370.58
Cash and Cash Equivalents, Period Increase (Decrease) -7.11-8.7954.14189.02204.06-142.72-5.992.43168.66